These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35741006)

  • 41. MOB2 suppresses GBM cell migration and invasion via regulation of FAK/Akt and cAMP/PKA signaling.
    Jiang K; Yao G; Hu L; Yan Y; Liu J; Shi J; Chang Y; Zhang Y; Liang D; Shen D; Zhang G; Meng S; Piao H
    Cell Death Dis; 2020 Apr; 11(4):230. PubMed ID: 32286266
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design, synthesis and biological evaluation of novel 1,3,4-thiadiazole derivatives as anti-glioblastoma agents targeting the AKT pathway.
    Szeliga M; Karpińska M; Rola R; Niewiadomy A
    Bioorg Chem; 2020 Dec; 105():104362. PubMed ID: 33074121
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
    Guan Y; He Y; Lv S; Hou X; Li L; Song J
    J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Harmine inhibits the proliferation and migration of glioblastoma cells via the FAK/AKT pathway.
    Zhu YG; Lv YX; Guo CY; Xiao ZM; Jiang QG; Kuang H; Zhang WH; Hu P
    Life Sci; 2021 Apr; 270():119112. PubMed ID: 33508300
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 17AEP-GA, an HSP90 antagonist, is a potent inhibitor of glioblastoma cell proliferation, survival, migration and invasion.
    Miekus K; Kijowski J; Sekuła M; Majka M
    Oncol Rep; 2012 Nov; 28(5):1903-9. PubMed ID: 22941268
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Matrine induces senescence of human glioblastoma cells through suppression of the IGF1/PI3K/AKT/p27 signaling pathway.
    Zhou W; Wang J; Qi Q; Feng Z; Huang B; Chen A; Zhang D; Li W; Zhang Q; Bjerkvig R; Li X; Wang J
    Cancer Med; 2018 Sep; 7(9):4729-4743. PubMed ID: 30079478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Demethoxycurcumin Suppresses Proliferation, Migration, and Invasion of Human Brain Glioblastoma Multiforme GBM 8401 Cells
    Su RY; Hsueh SC; Chen CY; Hsu MJ; Lu HF; Peng SF; Chen PY; Lien JC; Chen YL; Chueh FS; Chung JG; Yeh MY; Huang YP
    Anticancer Res; 2021 Apr; 41(4):1859-1870. PubMed ID: 33813391
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proteometabolomics of initial and recurrent glioblastoma highlights an increased immune cell signature with altered lipid metabolism.
    Cosenza-Contreras M; Schäfer A; Sing J; Cook L; Stillger MN; Chen CY; Villacorta Hidalgo J; Pinter N; Meyer L; Werner T; Bug D; Haberl Z; Kübeck O; Zhao K; Stei S; Gafencu AV; Ionita R; Brehar FM; Ferrer-Lozano J; Ribas G; Cerdá-Alberich L; Martí-Bonmatí L; Nimsky C; Van Straaten A; Biniossek ML; Föll M; Cabezas-Wallscheid N; Büscher J; Röst H; Arnoux A; Bartsch JW; Schilling O
    Neuro Oncol; 2024 Mar; 26(3):488-502. PubMed ID: 37882631
    [TBL] [Abstract][Full Text] [Related]  

  • 49. rAAV-mediated over-expression of acid ceramidase prevents retinopathy in a mouse model of Farber lipogranulomatosis.
    Zhang H; Nagree MS; Liu H; Pan X; Medin JA; Lipinski DM
    Gene Ther; 2023 Apr; 30(3-4):297-308. PubMed ID: 35902747
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acid ceramidase as a chemotherapeutic target to overcome resistance to the antitumoral effect of choline kinase α inhibition.
    Ramírez de Molina A; de la Cueva A; Machado-Pinilla R; Rodriguez-Fanjul V; Gomez del Pulgar T; Cebrian A; Perona R; Lacal JC
    Curr Cancer Drug Targets; 2012 Jul; 12(6):617-24. PubMed ID: 22515519
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alkaline ceramidase 3 (ACER3) hydrolyzes unsaturated long-chain ceramides, and its down-regulation inhibits both cell proliferation and apoptosis.
    Hu W; Xu R; Sun W; Szulc ZM; Bielawski J; Obeid LM; Mao C
    J Biol Chem; 2010 Mar; 285(11):7964-76. PubMed ID: 20068046
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity.
    Realini N; Solorzano C; Pagliuca C; Pizzirani D; Armirotti A; Luciani R; Costi MP; Bandiera T; Piomelli D
    Sci Rep; 2013; 3():1035. PubMed ID: 23301156
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ShRNA-based POLD2 expression knockdown sensitizes glioblastoma to DNA-Damaging therapeutics.
    Xu Q; Hu C; Zhu Y; Wang K; Lal B; Li L; Tang J; Wei S; Huang G; Xia S; Lv S; Laterra J; Jiang Y; Li Y
    Cancer Lett; 2020 Jul; 482():126-135. PubMed ID: 31954770
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acid Ceramidase in Melanoma: EXPRESSION, LOCALIZATION, AND EFFECTS OF PHARMACOLOGICAL INHIBITION.
    Realini N; Palese F; Pizzirani D; Pontis S; Basit A; Bach A; Ganesan A; Piomelli D
    J Biol Chem; 2016 Jan; 291(5):2422-34. PubMed ID: 26553872
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular Mechanism of Inhibition of Acid Ceramidase by Carmofur.
    Dementiev A; Joachimiak A; Nguyen H; Gorelik A; Illes K; Shabani S; Gelsomino M; Ahn EE; Nagar B; Doan N
    J Med Chem; 2019 Jan; 62(2):987-992. PubMed ID: 30525581
    [TBL] [Abstract][Full Text] [Related]  

  • 56. EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase.
    Wang SD; Rath P; Lal B; Richard JP; Li Y; Goodwin CR; Laterra J; Xia S
    Oncogene; 2012 Dec; 31(50):5132-43. PubMed ID: 22310282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Girdin maintains the stemness of glioblastoma stem cells.
    Natsume A; Kato T; Kinjo S; Enomoto A; Toda H; Shimato S; Ohka F; Motomura K; Kondo Y; Miyata T; Takahashi M; Wakabayashi T
    Oncogene; 2012 May; 31(22):2715-24. PubMed ID: 22020337
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Musashi-1 regulates AKT-derived IL-6 autocrinal/paracrinal malignancy and chemoresistance in glioblastoma.
    Chen HY; Lin LT; Wang ML; Lee SH; Tsai ML; Tsai CC; Liu WH; Chen TC; Yang YP; Lee YY; Chang YL; Huang PI; Chen YW; Lo WL; Chiou SH; Chen MT
    Oncotarget; 2016 Jul; 7(27):42485-42501. PubMed ID: 27285760
    [TBL] [Abstract][Full Text] [Related]  

  • 59. JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma.
    Zheng Q; Han L; Dong Y; Tian J; Huang W; Liu Z; Jia X; Jiang T; Zhang J; Li X; Kang C; Ren H
    Neuro Oncol; 2014 Sep; 16(9):1229-43. PubMed ID: 24861878
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Histotype-specific analysis of acid ceramidase expression in ovarian cancer.
    El-Balat A; Karn T; Holtrich U; Becker S; Kommoss S; Győrffy B; Anglesio MS; Huntsman DG; Drosos Z; Rody A; Gevensleben H; Hanker LC
    Virchows Arch; 2020 Jun; 476(6):855-862. PubMed ID: 31897818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.